Clinical Trials Logo

Filter by:
NCT ID: NCT04395963 Completed - Clinical trials for Simulation of Physical Illness

Eye Tracking and Simulated Postpartum Hemorrhage

Start date: November 20, 2019
Phase:
Study type: Observational

Eye tracking is the process of measuring an individual's eye movements in order to reflect their attentional behavior by using a device called an eye- tracker. This study uses eye-tracking methodology to observe the gaze patterns of participants to a high fidelity simulation scenario of postpartum hemorrhage acting in the role of leader to evaluate the relationship between eye-tracking patterns and leadership and team behavioral and technical skills.

NCT ID: NCT04395755 Completed - COVID-19 Clinical Trials

Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed

Start date: April 1, 2020
Phase:
Study type: Observational

Infertility is a severely distressing experience for many couples. Depression and anxiety are psychological disorders associated with infertility, and they may worsen during infertility treatments. This study times to understand the changes in the psychological status of infertile patients who had in vitro fertilization (IVF) treatment interrupted or postponed because of the COVID-19 pandemic.

NCT ID: NCT04395573 Completed - Obesity Clinical Trials

Real Time 3D Navigation and Traditional US to Identify Epidural Space Depth in Obese Pregnant

Accuro
Start date: March 30, 2021
Phase:
Study type: Observational

The aim of this study is to assess the accuracy of the Accuro Ultrasound Device in estimating the epidural space depth compared to the Standard Ultrasound Examination and with the measured needle depth during epidural and spinal insertion in pregnant obese patients

NCT ID: NCT04395482 Completed - covid19 Clinical Trials

Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury

TAC-COVID19
Start date: May 7, 2020
Phase:
Study type: Observational

This is a multicenter observational retrospective cohort study that aims to study the morphological characteristics of the lung parenchyma of SARS-CoV2 positive patients identifiable in patterns through artificial intelligence techniques and their impact on patient outcome.

NCT ID: NCT04394026 Completed - COVID Clinical Trials

Imaging Feature of SARS-CoV2 Infection

COVID19IF
Start date: April 16, 2020
Phase:
Study type: Observational

The novel coronavirus SARS-CoV2 clinically presents with pneumonia, characterised by fever, cough, dyspnea. The severity of the disease varies widely with evidence of mild disease in the majority of confirmed cases, severe pneumonia-dyspnea, hypoxia or lung involvement at imaging within 24-48 hours- and critical disease with respiratory failure, shock or multi-organ failure in particular patient cohorts. Imaging plays a key role is diagnosis and progression of this disease.

NCT ID: NCT04393805 Completed - COVID-19 Clinical Trials

Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto

HETHICO
Start date: June 1, 2020
Phase:
Study type: Observational

The HETHICO study aims to collect retrospectively documented clinical information on patients hospitalized in Veneto Region (Italy) for SARS-COVID-2 infection in 2 types of settings, medical environment (COORTE MED), and intensive / sub-intensive (COORTE ICU), to assess the safety and possible efficacy of the anticoagulant treatments used for thromboprophylaxis, or in preventing thrombotic complications related to hospitalization from COVID-19.

NCT ID: NCT04393753 Completed - Clinical trials for Merkel Cell Carcinoma

Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1

MERKLIN2
Start date: October 13, 2020
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well domatinostat (4SC-202) works in combination with avelumab in adult patients with advanced unresectable and/or metastatic Merkel Cell Carcinoma that have progressed on a previous therapy with an anti-PD-(L)1 antibody

NCT ID: NCT04392453 Completed - Stroke Clinical Trials

Upper Limb Robotic Rehabilitation During COVID-19 Outbreak

Start date: October 26, 2020
Phase: N/A
Study type: Interventional

The COVID-19 outbreak requires a rapid re-shaping of the entire organization of the rehabilitation services. This includes the design and planning of appropriate rehabilitation settings, intervention and logistics for organizing space for patients. The aims of this study are: (a) to evaluate the feasibility of the bedside use of a novel rehabilitation device for upper limb in patients with stroke; (b) to evaluate the motor and cognitive outcomes of the treatment; (c) to validate the instrumental outcomes provided by the device.

NCT ID: NCT04392245 Completed - Clinical trials for Proctologic Practice During COVID-19

Proctologic Practice and Covid-19

PROCTOLOCK
Start date: April 15, 2020
Phase:
Study type: Observational

Cross-sectional non-incentivized worldwide web survey. A worldwide survey of 1050 respondents showed that proctologic practice has been seriously affected by the pandemic. Age, gender and level of hospital preparedness predicted the change of status of surgical and outpatient activities. The results of our study may inform the development of strategies to reopen activities while protecting frontline healthcare workers.

NCT ID: NCT04391205 Completed - Clinical trials for Upper Extremity Deep Vein Thrombosis, Secondary

A Study to Investigate the Possible Causes of Secondary Effects During Use of Peripheral Midline Type Catheter in Patients Hospitalized in Different Care Settings

MIDES
Start date: April 26, 2017
Phase:
Study type: Observational

Although the use of peripheral venous catheters (CVP) with brachial insertion with echo-guide (Midline) has increased significantly over the last 5-10 years, there are no sensitive data concerning complications in the literature during their use, particularly as regards incidence of thrombotic complication.The prospective observational study will enroll all the patients admitted to Home Health Hospitalization service, Geriatric Department and Intermediate Care service, to whom a Midline-type CVP will be placed for infusional therapy and who will give their consent to participate.